Exploring Novel Endocannabinoid Pathways in Sclerotic Chronic Graft-Versus-Host-Disease

Key Points

• Chronic graft-versus-host disease shows a potential link to novel endocannabinoid pathways, highlighting new areas for treatment.
• A significant finding includes altered immune response markers which may inform future therapies.
• Assessment using clinical observations and biomarker profiling reveals intricate relationships between sclerosis and endocannabinoids.
• Understanding these pathways may enable the development of targeted therapies in patients with chronic graft-versus-host disease.